About

Publications While At HealthPartners

selected publications

Journal Article

A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease. 

Drugs and Aging. 2021

Double-blind placebo-controlled pilot investigation of the safety of a single dose of rapid-acting intranasal insulin in Down syndrome. 

Drugs in R&D. 2020

A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein e4 carriers with mild-moderate Alzheimer's disease. 

CNS drugs. 2014

Conference Poster

Routine cognitive screening in a neurology practice: impact on physician behavior [poster]

2015

Failure on cognitive screening predicts increased healthcare utilization [poster]

2014

Routine cognitive screening in a general neurology clinic: impact on physician behavior [poster]

2014

The effect of intranasal rapid acting insulin on ApoE4 carriers with mild-moderate Alzheimer's disease [poster]

2013

The 6th Vital Sign Project: does cognitive screening in the elderly population improve clinical care [poster]?

2012

Contact

full name

M. Pyle

Quick Info

 

Collaboration

Co-author network

Map of science